Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer
- PMID: 23520464
- PMCID: PMC3592848
- DOI: 10.1371/journal.pone.0057243
Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer
Abstract
Accumulating evidence suggests that alterations in immune function may be important in the etiology of papillary thyroid cancer (PTC). To identify genetic markers in immune-related pathways, we evaluated 3,985 tag single nucleotide polymorphisms (SNPs) in 230 candidate gene regions (adhesion-extravasation-migration, arachidonic acid metabolism/eicosanoid signaling, complement and coagulation cascade, cytokine signaling, innate pathogen detection and antimicrobials, leukocyte signaling, TNF/NF-kB pathway or other) in a case-control study of 344 PTC cases and 452 controls. We used logistic regression models to estimate odds ratios (OR) and calculate one degree of freedom P values of linear trend (P(SNP-trend) ) for the association between genotype (common homozygous, heterozygous, variant homozygous) and risk of PTC. To correct for multiple comparisons, we applied the false discovery rate method (FDR). Gene region- and pathway-level associations (P(Region) and P(Pathway)) were assessed by combining individual P(SNP-trend) values using the adaptive rank truncated product method. Two SNPs (rs6115, rs6112) in the SERPINA5 gene were significantly associated with risk of PTC (P(SNP-FDR)/P(SNP-trend)= 0.02/6×10(-6) and P(SNP-FDR)/P(SNP-trend)= 0.04/2×10(-5), respectively). These associations were independent of a history of autoimmune thyroiditis (OR = 6.4; 95% confidence interval: 3.0-13.4). At the gene region level, SERPINA5 was suggestively associated with risk of PTC (P(Region-FDR)/P(Region)= 0.07/0.0003). Overall, the complement and coagulation cascade pathway was the most significant pathway (P(Pathway)= 0.02) associated with PTC risk largely due to the strong effect of SERPINA5. Our results require replication but suggest that the SERPINA5 gene, which codes for the protein C inhibitor involved in many biological processes including inflammation, may be a new susceptibility locus for PTC.
Conflict of interest statement
Figures
Similar articles
-
Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.Carcinogenesis. 2016 Jul;37(7):677-684. doi: 10.1093/carcin/bgw047. Epub 2016 Apr 28. Carcinogenesis. 2016. PMID: 27207655 Free PMC article.
-
Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.Thyroid. 2012 Feb;22(2):151-6. doi: 10.1089/thy.2011.0309. Epub 2012 Jan 6. Thyroid. 2012. PMID: 22224819 Free PMC article.
-
Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.Laryngoscope. 2012 May;122(5):1040-2. doi: 10.1002/lary.23209. Epub 2012 Jan 24. Laryngoscope. 2012. PMID: 22275265 Free PMC article.
-
Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.Tumour Biol. 2016 Jan;37(1):979-87. doi: 10.1007/s13277-015-3882-4. Epub 2015 Aug 12. Tumour Biol. 2016. PMID: 26264616
-
Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.Endocr Relat Cancer. 2012 May 24;19(3):333-44. doi: 10.1530/ERC-11-0372. Print 2012 Jun. Endocr Relat Cancer. 2012. PMID: 22389382 Free PMC article.
Cited by
-
Mining for encrypted peptide antibiotics in the human proteome.Nat Biomed Eng. 2022 Jan;6(1):67-75. doi: 10.1038/s41551-021-00801-1. Epub 2021 Nov 4. Nat Biomed Eng. 2022. PMID: 34737399
-
Increased risk of papillary thyroid cancer related to hormonal factors in women.Tumour Biol. 2015 Jul;36(7):5127-32. doi: 10.1007/s13277-015-3165-0. Epub 2015 Feb 11. Tumour Biol. 2015. PMID: 25669169
-
Association of rs6983267 Polymorphism and Thyroid Cancer Susceptibility: A Systematic Review and Meta-Analysis.Med Sci Monit. 2016 Jun 2;22:1866-71. doi: 10.12659/msm.896507. Med Sci Monit. 2016. PMID: 27251952 Free PMC article. Review.
-
Evaluation the Presence of SERPINA5 (Exon 3) and FTO rs9939609 Polymorphisms in Papillary Thyroid Cancer Patients.Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3641-3646. doi: 10.31557/APJCP.2021.22.11.3641. Asian Pac J Cancer Prev. 2021. PMID: 34837923 Free PMC article.
-
SERPINA5 promotes tumour cell proliferation by modulating the PI3K/AKT/mTOR signalling pathway in gastric cancer.J Cell Mol Med. 2022 Sep;26(18):4837-4846. doi: 10.1111/jcmm.17514. Epub 2022 Aug 24. J Cell Mol Med. 2022. PMID: 36000536 Free PMC article.
References
-
- Sipos JA, Mazzaferri EL (2010) Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 22: 395–404. - PubMed
-
- Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295: 2164–2167. - PubMed
-
- Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, et al. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141: 259–277. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous